COPD Drugs Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide COPD Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.8% during the forecast period.

    This report presents the market size and development trends by detailing the COPD Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the COPD Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of COPD Drugs industry and will help you to build a panoramic view of the industrial development.

    COPD Drugs Market, By Type:

    • Bronchodilators

    • PDE-4 Inhibitors

    • Steroids

    • Combination Therapies

    • Others

    COPD Drugs Market, By Application:

    • Hospitals

    • Clinics

    • Others

    Some of the leading players are as follows:

    • GlaxoSmithKline

    • Merck

    • Boehringer Ingelheim

    • Pfizer

    • Novartis

    • AstraZeneca

    • Roche Holding AG

    • Abbott Laboratories

    • Teva Pharmaceutical Industries

    • Mylan NV

    • Vectura Group

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of COPD Drugs Market

    • 1.3 Market Segment by Type

      • 1.3.1 Bronchodilators

      • 1.3.2 PDE-4 Inhibitors

      • 1.3.3 Steroids

      • 1.3.4 Combination Therapies

      • 1.3.5 Others

    • 1.4 Market Segment by Application

      • 1.4.1 Hospitals

      • 1.4.2 Clinics

      • 1.4.3 Others

    • 1.5 Market Segment by Regions

      • 1.5.1 North America COPD Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe COPD Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific COPD Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA COPD Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of COPD Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of COPD Drugs by Major Types

      • 3.4.1 Bronchodilators

      • 3.4.2 PDE-4 Inhibitors

      • 3.4.3 Steroids

      • 3.4.4 Combination Therapies

      • 3.4.5 Others

    4 Segmentation of COPD Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of COPD Drugs by Major End-Users

      • 4.4.1 Hospitals

      • 4.4.2 Clinics

      • 4.4.3 Others

    5 Market Analysis by Major Regions

    • 5.1 Global COPD Drugs Production Analysis by Top Regions

    • 5.2 Global COPD Drugs Consumption Analysis by Top Regions

    • 5.3 Global COPD Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America COPD Drugs Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe COPD Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific COPD Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA COPD Drugs Production, Import, Consumption and Export Analysis

    6 Product Circulation of COPD Drugs Market among Top Countries

    • 6.1 Top 5 Export Countries in COPD Drugs Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in COPD Drugs Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in COPD Drugs Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in COPD Drugs Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in COPD Drugs Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in COPD Drugs Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America COPD Drugs Landscape Analysis

    • 7.1 North America COPD Drugs Landscape Analysis by Top Countries

      • 7.1.1 United States COPD Drugs Market Volume and Growth Rate

      • 7.1.2 Canada COPD Drugs Market Volume and Growth Rate

      • 7.1.3 Mexico COPD Drugs Market Volume and Growth Rate

    8. Europe COPD Drugs Landscape Analysis

    • 8.1 Europe COPD Drugs Landscape Analysis by Major Types

    • 8.2 Europe COPD Drugs Landscape Analysis by Major End-Users

    • 8.3 Europe COPD Drugs Landscape Analysis by Top Countries

      • 8.3.1 Germany COPD Drugs Market Volume and Growth Rate

      • 8.3.2 UK COPD Drugs Market Volume and Growth Rate

      • 8.3.3 France COPD Drugs Market Volume and Growth Rate

      • 8.3.4 Italy COPD Drugs Market Volume and Growth Rate

      • 8.3.5 Spain COPD Drugs Market Volume and Growth Rate

      • 8.3.6 Belgium COPD Drugs Market Volume and Growth Rate

      • 8.3.7 Poland COPD Drugs Market Volume and Growth Rate

      • 8.3.8 Russia COPD Drugs Market Volume and Growth Rate

      • 8.3.9 Turkey COPD Drugs Market Volume and Growth Rate

      • 8.3.10 Netherlands COPD Drugs Market Volume and Growth Rate

      • 8.3.11 Portugal COPD Drugs Market Volume and Growth Rate

      • 8.3.12 Denmark COPD Drugs Market Volume and Growth Rate

      • 8.3.13 Finland COPD Drugs Market Volume and Growth Rate

      • 8.3.14 Iceland COPD Drugs Market Volume and Growth Rate

      • 8.3.15 Norway COPD Drugs Market Volume and Growth Rate

      • 8.3.16 Sweden COPD Drugs Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific COPD Drugs Landscape Analysis

    • 9.1 Asia Pacific COPD Drugs Landscape Analysis by Top Countries

      • 9.1.1 China COPD Drugs Market Volume and Growth Rate

      • 9.1.2 Japan COPD Drugs Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) COPD Drugs Market Volume and Growth Rate

      • 9.1.4 India COPD Drugs Market Volume and Growth Rate

      • 9.1.5 ASEAN COPD Drugs Market Volume and Growth Rate

      • 9.1.6 South Korea COPD Drugs Market Volume and Growth Rate

    10 LAMEA COPD Drugs Landscape Analysis

    • 10.1 LAMEA COPD Drugs Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries COPD Drugs Market Volume and Growth Rate

      • 10.1.2 Brazil COPD Drugs Market Volume and Growth Rate

      • 10.1.3 North Africa COPD Drugs Market Volume and Growth Rate

      • 10.1.4 South Africa COPD Drugs Market Volume and Growth Rate

      • 10.1.5 Argentina COPD Drugs Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 GlaxoSmithKline

      • 11.1.1 GlaxoSmithKline Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Merck

      • 11.2.1 Merck Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Boehringer Ingelheim

      • 11.3.1 Boehringer Ingelheim Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Pfizer

      • 11.4.1 Pfizer Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Novartis

      • 11.5.1 Novartis Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 AstraZeneca

      • 11.6.1 AstraZeneca Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Roche Holding AG

      • 11.7.1 Roche Holding AG Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Abbott Laboratories

      • 11.8.1 Abbott Laboratories Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Teva Pharmaceutical Industries

      • 11.9.1 Teva Pharmaceutical Industries Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Mylan NV

      • 11.10.1 Mylan NV Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Vectura Group

      • 11.11.1 Vectura Group Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 115 Figures and 157 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of Bronchodilators

    • Figure Market Size and Growth Rate of PDE-4 Inhibitors

    • Figure Market Size and Growth Rate of Steroids

    • Figure Market Size and Growth Rate of Combination Therapies

    • Figure Market Size and Growth Rate of Others

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Others

    • Figure North America COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure United States COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Canada COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Europe COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Germany COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure UK COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure France COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Italy COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Spain COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Poland COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Russia COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure China COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Japan COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Australia COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure India COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure GCC COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina COPD Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of COPD Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of COPD Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of COPD Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of COPD Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Bronchodilators

    • Figure Market Size and Growth Rate of PDE-4 Inhibitors

    • Figure Market Size and Growth Rate of Steroids

    • Figure Market Size and Growth Rate of Combination Therapies

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of COPD Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of COPD Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Others

    • Table Global COPD Drugs Production by Major Regions

    • Table Global COPD Drugs Production Share by Major Regions

    • Table Global COPD Drugs Consumption by Major Regions

    • Table Global COPD Drugs Consumption Share by Major Regions

    • Table North America COPD Drugs Production, Import, Consumption and Export Analysis

    • Table Europe COPD Drugs Production, Import, Consumption and Export Analysis

    • Table Asia Pacific COPD Drugs Production, Import, Consumption and Export Analysis

    • Table LAMEA COPD Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in COPD Drugs Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in COPD Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in COPD Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in COPD Drugs Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America COPD Drugs Consumption by Major Countries from 2014 to 2026

    • Table North America COPD Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure North America COPD Drugs Consumption Share by Major Countries in 2014

    • Figure North America COPD Drugs Consumption Share by Major Countries in 2018

    • Figure North America COPD Drugs Consumption Share by Major Countries in 2026

    • Figure United States COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Europe COPD Drugs Consumption by Types from 2014 to 2026

    • Table Europe COPD Drugs Consumption Share by Types from 2014 to 2026

    • Table Europe COPD Drugs Consumption by End-Users from 2014 to 2026

    • Table Europe COPD Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Europe COPD Drugs Consumption by Major Countries from 2014 to 2026

    • Table Europe COPD Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure UK COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure France COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific COPD Drugs Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific COPD Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure China COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure India COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa COPD Drugs Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa COPD Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries COPD Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Holding AG

    • Figure Sales and Growth Rate Analysis of Roche Holding AG

    • Figure Revenue and Market Share Analysis of Roche Holding AG

    • Table Product and Service Introduction of Roche Holding AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries

    • Table Product and Service Introduction of Teva Pharmaceutical Industries

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan NV

    • Figure Sales and Growth Rate Analysis of Mylan NV

    • Figure Revenue and Market Share Analysis of Mylan NV

    • Table Product and Service Introduction of Mylan NV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vectura Group

    • Figure Sales and Growth Rate Analysis of Vectura Group

    • Figure Revenue and Market Share Analysis of Vectura Group

    • Table Product and Service Introduction of Vectura Group

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.